TABLE 1.
Demographic and general health data collected from the participants by study group
| Demographic | Study group |
||||
|---|---|---|---|---|---|
| BNT162b2 | AZD1222 | Convidecia | Sputnik V | CoronaVac | |
| No. of participants recruited | 171 | 209 | 203 | 179 | 214 |
| Previous infection (no. [%]) | |||||
| Yes (by IgG and RBD test) | 92 (53.8) | 87 (41.6) | 65 (32.0) | 76 (42.5) | 114 (53.3) |
| Yes (by questionnaire) | 27 (15.8) | 46 (21.9) | 32 (15.8) | 34 (19.0) | 54 (25.2) |
| No (by IgG and RBD test) | 79 (46.2) | 122 (58.4) | 138 (68.0) | 103 (57.5) | 100 (46.7) |
| No (by questionnaire) | 144 (84.2) | 163 (78.1) | 171 (84.2) | 145 (81.0) | 160 (74.8) |
| Asymptomatic (no. [%]) | 65 (38.0) | 41 (19.6) | 33 (16.3) | 42 (23.5) | 60 (28.0) |
| Age range (mean) | 27–76 (55) | 19–78 (50) | 21–60 (39) | 20–60 (49) | 20–63 (36) |
| Sex | |||||
| No. (%) female | 113 (66.1) | 135 (64.3) | 150 (73.9) | 104 (58.1) | 123 (57.5) |
| No. (%) male | 58 (33.9) | 75 (35.7) | 53 (26.1) | 75 (41.9) | 91 (42.5) |
| Hypertension (no. [%]) | 17 (9.9) | 48 (22.9) | 10 (4.9) | 39 (21.8) | 15 (7.0) |
| Diabetes (no. [%]) | 10 (5.9) | 36 (17.1) | 6 (3.0) | 27 (15.1) | 8 (3.7) |
| Obesity (no. [%]) | 48 (28.0) | 53 (25.2) | 40 (19.7) | 45 (25.1) | 62 (29.0) |
| HIV (no. [%]) | 2 (1.0) | 1 (0.6) | 2 (0.9) | ||
| Another immunosuppression (no. [%]) | 2 (1.2) | 7 (3.3) | 7 (3.4) | 4 (2.2) | 3 (1.4) |
| Pregnancy (no. [%]) | 1 (0.5) | 5 (2.8) | 3 (1.4) | ||